I. INTRODUCTION
Generally, cancer is the second leading cause of death in the United States. One of three Americans people falling victim to cancer [1] . Cervical cancer is one of the most common cancer in women worldwide. Prevalence of this cancer is second highest in the development country. Cervical cancer screening is an essential part of a woman's routine health care. This routine screening can decrease the prevalence of cervical cancer in Oceanian countries, European countries, and North America. With this routine screening, we can do an early prevention, so the cells can't grow out of control [2] . In 2016, American Cancer Society estimated 4.120 women died in 12.990 cases [3] .
Standard treatments for cervical cancer are surgery, radiation therapy, and chemotherapy. But, alternative treatment can also use traditional medicine. There is a traditional therapy used as an adjuvant therapy for cervical cancer. These plants like grass that grows in the swamps, from Bangka Belitung Island, Indonesia. People in Bangka Belitung are used to using plants for preventing cancer. This grass name is Eriocaulon Manuscript received November 15, 2016; revised March 28, 2017 cinereum R.Br included in Euricaulon family. Grass Gong has an anticancer activity. Traditional Chinese Medicine (TCM) has a combination therapy for cancer from Eriocaulon family, using Eriocaulon sieboldianum as an adjuvant therapy [4] . Eriocaulon australe species found in China has a cytotoxic activity for A549 cell, MCF-7, and HeLa cell [5] .
The compounds of Eriocaulon cinereum R.Br abundant is isoflavones and flavones with some naphtha pyranones. Overall identification with high performance liquid chromatography DAD there are fifteen flavonoid. Figure 1 describe structure of compound from Eriocaulon cinereum R. (8) , Gerontoisoflavone A (9), 7,3-Dihydroxy-5,4,5-trimethoxyisoflavone (10), Hispidulin (11), Iristectorigenin A (12), 5,7,3-Trihydroxy-6,4,5-trimethoxyisoflavone (13), (R)-Semixanthomegnin (14), (R)-Semivioxanthin (15). The high concentration compound of Eriocaulon cinereum R.Br is hispidulin, between 40-50 %. Hispidulin (11), it's one of flavonoids group. That is the major characteristic compound from Eriocaulon cinereum R.Br with iristectorigenin A (12) and irigenin (13) [6] . Hispidulin reported having activities inhibits of ROS production and improve the functions of mitochondria [7] . ROS reported can be a trigger become cancer.
Tetrazolium-based colorimetric assay (MTT test) is a method that simply counting in vitro living cells [8] . This method is carried out on searches immunological effects, cancer and biocompatibility evaluation. MTT assay is a method that can be accounted for the results, other than that this method is also relatively quick and reproducible. The objective of this research was to assess the potential of Eriocaulon cinereum R.Br as an anti-cancer agent. The potential assessment carried out by how strongly the ethanolic extract from Eriocaulon cinereum R.Br inhibit proliferation the HeLa cell. Grass Gong has a potential value as an anticancer, especially cervical cancer. It's important to explore the anticancer activity in cervical cancer's cell in order to know about how big potential to cure cancer. Identification of the compound is also important to find the secondary metabolites in this plant. 
II. MATERIAL AND METHODS

A. Cell Lines, Chemical, and Biochemicals
Cervical cancer cell (HeLa) obtained from Parasitologi Laboratorium Medicine Faculty of Gadjah Mada University. Etanol 96%, PLGA, PVA 2,5%, RPMI 1641 (Sigma Aldrich), Fungizon 0,5%, Penicillin/Streptomycin Solution 1%, Fetal bovine serum 10% (FBS), SDS 10%, MTT 0,5%.
B. Sample Collection
The herbs of Eriocaulon cinereum R.Br was collected on the month of July 2016 from Bangka Belitung Island. The Fresh herbs were packed in a polyethylene bag and transported to the laboratory.
C. Preparation of Sample
The whole herbs of Eriocaulon cinereum R.Br were washed with water and dried in the drying cabinet at 50oC for 4 days. The dry herbs were ground using a grinder until smooth and escaped in the mesh 60. The whole herbs powder of Eriocaulon cinereum R,Br were packed in glass containers until extraction.
D. Extraction Procedure
The dried powder of Eriocaulon cinereum R.Br (25 g) was extracted with ethanol 96% (250 ml) using Ultrasound Assisted Extraction with modification [9] . After extraction, it was filtered and evaporated by vacuum rotary evaporator to give viscous masses. The crude extract (5,24 g) were packed in a glass container.
E. Determine of Total Phenol by Folin-Reagent Method
Total phenol content was determined by Folin Ciocalteu reagent method [10] . Gallic acid calibration was prepared by various concentration (100, 50, 25, 12.5 and 6.25 µg/ml). The 3mg extract was dissolved in 10ml methanol. 1 ml of Gallic acid and the extract is taken in flasks then added by water (9ml). 1ml Folin-Ciocalteu reagent and 10 ml Na 2 CO 3 (7%) was added to each flask. Then all flasks were kept in a dark place for 90 min. The absorbance was measured by using UV-Vis spectrophotometer at wavelength 765 nm.
F. Determine of Flavonoids Content
The ethanolic crude extract was estimated by aluminum chloride colorimetric method as describe by Asma et al [11] . Extract (0.5ml) with concentration 300 µg/ml was added 1.5 ml ethanol. Then dissolving by 1 ml AlCl3 anhydrate (10%) and added by 0.1 ml potassium acetate1M and water 2.8 ml. Then mixed the solution and waiting for 30 min. The absorbance was measured by using UV-Vis spectrophotometer at wavelength 415 nm. Quercetine standard was used for the calibration curve.
G. Determine of Compounds from Extract
Determine chemical constituents of the extract is used a reagent spray. Dragendorff reagent for alkaloid compounds. Anisaldehid-Sulfuricacid for terpenoids.
H. Determine of Proliferative or Inhibitor Effects of Eriocaulon Cinereum R.Br Extract on Cervical Cancer Cell (HeLa)
The Eriocaulon cinereum R.Br extract was applied to HeLa cells to determine a proliferative activity [12] . The Eriocaulon cinereum R.Br extract was dissolved in DMSO at a concentration of 500 µg/ml, 250 µg/ml, 125 µg/ml, 62.5 µg/ml, 31.25 µg/ml, 15.62 µg/ml, 7.81 µg/ml and 3.90 µg/ml.
A 10ml volume of growth media (RPMI 1640) suspension with HeLa cells was centrifuged at 1500 rpm for 10 minutes. The supernatant was poured off and resuspended in 10 ml media and incubation on the CO2 incubator at 37oC. Cells were observed under the microscope and if the number of cells enough (confluent) take 10 µL Cells then counted on a hemacytometer.
Cells were seeded at 10,000-50,000 cells/ ml placed in 96-well plates. Twenty-four hours later, added the Eriocaulon cinereumR.Br (100 µL). The plate was incubated for a further 24 hours. The medium was removed from the well and 100 µL of a new medium and 10 µL MTT (0.5%) was added. The Plate was incubated for 3 hours and then added 10% SDS. The plate was incubation 4 hours and kept in dark place at room temperature. The absorbance was measured by Elisa reader at wavelength 550 nm. Controls for the assay include cells with DMSO and cells alone.
III. RESULT AND DISCUSSION
The result of study presented in Table I , including total phenolic, total flavonoid and proliferation activity on HeLa cells. The total phenol content of extract Eriocaulon cinereum R.Br was determined by FolinCiocalteu method. The total phenolic content of the extract was expressed as miligram of gallic acid equivalent. The result was 18.983 mg/g gallic acid equivalent as dry weight extract. The total content of phenolic compound was determined from the regression equation of the calibration curve (y=0.00574x + 0.00625, R2 = 0.987) and expressed in Galic Acid Equivalent.
The total flavonoid of extract Eriocaulon cinereumR.Br was reported as quercetin equivalent. The result was 63.518 mg/g quercetin equivalent as dry weight extract. Determining the total flavonoid content using AlCl3 is based on the formation of the stable complex between aluminum chloride and the keto and hydroxyl group of flavones and flavonoids [10] . The total flavonoids in extract was determined from regression equation of the calibration curve (y= 0.00422x + 0.0106, R2 = 0.985) and expressed in quercetin equivalent (QE).
The chemical compound of extract was positif as terpenoid compound, but negative for alkaloid. it is not visible from the appearance of red spots on the test results after being sprayed Dragendorff reagent.
The result of treatment of HeLa cells with ethanolic extract of Eriocaulon cinereum R.Br showed by IC 50 value, it was 427.79 µg/ml. In this study, extract of Eriocaulon cinereum R.Br. has monitored growthproliferative effect in HeLa cells. The proliferative activity in HeLa cells from Eriocaulon cinereum R.Br has never been reported. Previously, the proliferative effects in HeLa cells have been reported from other species from Eriocaulon. One of the species is Eriocaulon austral from China, the extract displaying a cytotoxic effect in A549, MCF-7 and HeLa Cells [5] . The another species is Eriocaulon sieboldianum used as adjuvant cancer therapy [4] .
Flavonoids from eriocaulon family has proven to anticancer activity in HeLa cells. As flavonoid derived from species Eriocaulon australe. Reported that hispidulin have HeLa cell growth inhibition of IC 50 10.38 µg/ml. In addition, there are also flavonoids Jaceosidin and 3'.4'-methylenedioxyorobol who have HeLa cell growth inhibition with IC 50 15.29 µg/ml and 10.63 µg/ml [5] .
From these results, extract of Eriocaulon cinereum R.Br has potential as an anticancer. The results prove that the people from Bangka Belitung Island were appropriate. But, there is still need further studies to know in vivo activity of an animal model and also in humans for find best doses therapy. Other than that, it needs to figure out the active compound anticancer from Eriocaulon cinereum R.Br. 
IV. CONCLUSION
The study has shown that an in vitro exposure of HeLa cells to Eriocaulon cinereum R.Br extract, inhibit the growth HeLa cells. Eriocaulon cinereum R.Br has potential as an anti-cancer drug. The effect of Eriocaulon cinereum R.Br requires in-depth study in vivo in an animal model to figure out the activity against tumor cells. Then, it is also necessary to figure out on chemical compounds responsible for the activity.
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